Adam Crystal sold $112K of TNGX stock

Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 5,000 shares of TNGX stock worth $112K, per an SEC Form 4 filed Nov 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 2, 2026, 3 days before it was made public.

TNGX has moved -1.2% since the trade date, from $21.76 to $21.50 (Nov 6, 2026 close).